|
Volumn 32, Issue 5, 2005, Pages 637-639
|
A phase I study of TS-1 and weekly cisplatin in patients with advanced gastric cancer
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
OXONIC ACID;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TEGAFUR;
ADULT;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
HUMAN;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NAUSEA;
PHASE 1 CLINICAL TRIAL;
STOMACH TUMOR;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
HUMANS;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NAUSEA;
OXONIC ACID;
PYRIDINES;
STOMACH NEOPLASMS;
TEGAFUR;
|
EID: 19544384431
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|